MRI study aims to uncover how brain small vessel disease progresses

NCT ID NCT05703386

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study at Johns Hopkins University will follow 50 people who have had a stroke and have risk factors like high blood pressure, high cholesterol, or diabetes. Researchers will use repeated MRI scans over about 15 months to track changes in the brain's white matter. The goal is to better understand how cerebral small vessel disease develops and leads to thinking and memory problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kennedy Krieger Institute

    RECRUITING

    Baltimore, Maryland, 21205, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how small vessel disease in the brain leads to cognitive decline, pointing toward future prevention strategies.

What could go wrong

This is an observational imaging study, not a treatment trial. It may not directly lead to new therapies, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases dementia diabetes mellitus hyperlipidemia hypertensive disorder Ischemic Stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.